Header Logo

Connection

Marshall Goldin to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Marshall Goldin has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.